Changes in public policy are also helping drive wider usage of the drugs. A Trump administration agreement last year with GLP-1 manufacturers Eli Lilly and Novo Nordisk lowered the cost of Ozempic and Wegovy to between $150 and $350 per month, down from roughly $1,000 per month. The Medicare GLP-1 Bridge program also provides eligible Medicare beneficiaries with access to GLP-1 drugs for $50 a month. [...] Watch CBS News

More people now use GLP-1s for weight loss than for other health conditions, research finds

October 22, 2026 / 5:58 PM EDT / CBS News

More Americans are now taking GLP-1 drugs to shed some pounds than to treat diabetes and other health conditions for which the medications were originally prescribed, new research shows. [...] In a first-of-its-kind study, the researchers will examine how GLP-1s influence the body's reward system, a network of brain structures that reinforces certain behaviors, to see whether the drugs suppress temptations such as luxury purchases, gambling or other activities that people often find hard to control.

Edited by Alain Sherter

In:

© 2026 CBS Interactive Inc. All Rights Reserved.

Doctor explains how GLP-1 drugs could help reduce gambling, shopping addiction

(02:44)